XORTX Therapeutics Inc. Made Big Gain
XORTX Therapeutics Inc. (XRTX:NASDAQ) shot up at $1.83, a gain of 59.1%. On Mon, May 02, 2022, XRTX:NASDAQ hit a New 2-Week Low of $1.16. The stock appeared on our News Catalysts scanner on Tue, May 03, 2022 at 02:32 PM in the 'BIOTECH' category. From Tue, Apr 19, 2022, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Wed, Mar 23, 2022 at $2.48 with a volume of 4M+.
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- Blue Water Vaccines Inc. (BWV:NASDAQ), 93.11%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 59.13%
- Ostin Technology Group Co. Ltd. (OST:NASDAQ), 57.28%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 54%
- Titan Medical Inc. (TMDI:NASDAQ), 32.7%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 31.58%
- Belite Bio Inc (BLTE:NASDAQ), 30.78%
- Sesen Bio, Inc. (SESN:NASDAQ), 29.97%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 28.23%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 25.24%